Samsara BioCapital, LLC - RHYTHM PHARMACEUTICALS INC ownership

RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 173 filers reported holding RHYTHM PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.4%.

Quarter-by-quarter ownership
Samsara BioCapital, LLC ownership history of RHYTHM PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$7,088,886
-5.2%
172,6470.0%1.48%
+28.3%
Q1 2024$7,480,795
-5.7%
172,6470.0%1.16%
-6.3%
Q4 2023$7,936,583
+0.3%
172,647
-50.0%
1.24%
-49.0%
Q3 2023$7,915,842
+39.0%
345,2930.0%2.42%
+142.5%
Q2 2023$5,693,882
-7.6%
345,2930.0%1.00%
-21.5%
Q1 2023$6,160,027
-38.7%
345,2930.0%1.27%
-41.2%
Q4 2022$10,054,932
+18.9%
345,2930.0%2.16%
+9.7%
Q3 2022$8,460,000
+490.4%
345,2930.0%1.97%
+416.5%
Q2 2022$1,433,000
-64.0%
345,2930.0%0.38%
-61.8%
Q1 2022$3,978,000
+15.4%
345,2930.0%1.00%
+49.6%
Q4 2021$3,446,000
-12.1%
345,293
+15.0%
0.67%
+8.8%
Q3 2021$3,922,000
-33.3%
300,2930.0%0.62%
-15.3%
Q2 2021$5,880,000
+37.5%
300,293
+49.4%
0.73%
-8.0%
Q1 2021$4,276,000
-28.5%
201,0460.0%0.79%
+31.3%
Q4 2020$5,977,000
+17.4%
201,046
-14.4%
0.60%
-57.6%
Q3 2020$5,089,000
-17.4%
234,846
-15.0%
1.42%
-28.4%
Q2 2020$6,161,000
+46.5%
276,2890.0%1.98%
-18.1%
Q1 2020$4,205,000276,2892.42%
Other shareholders
RHYTHM PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Opaleye Management Inc. 735,000$13,112,4003.93%
NEA Management Company, LLC 2,909,956$51,913,6153.59%
Frazier Life Sciences Management, L.P. 2,164,739$38,618,9442.80%
RA Capital Management 5,516,067$98,406,6352.23%
Samsara BioCapital, LLC 345,293$6,160,0271.27%
Rock Springs Capital Management LP 1,597,123$28,492,6740.68%
Baker Brothers Advisors 6,498,267$115,929,0830.63%
HighVista Strategies LLC 35,478$632,9280.52%
Nan Fung Group Holdings Ltd 32,520$580,1570.40%
GREAT POINT PARTNERS LLC 97,544$1,740,1850.34%
View complete list of RHYTHM PHARMACEUTICALS INC shareholders